Back to Search
Start Over
Network degeneration in Parkinson’s disease: multimodal imaging of nigro-striato-cortical dysfunction
- Source :
- Brain 143(3), 944-959 (2020). doi:10.1093/brain/awaa019
- Publication Year :
- 2020
- Publisher :
- Oxford University Press (OUP), 2020.
-
Abstract
- The spreading hypothesis of neurodegeneration assumes an expansion of neural pathologies along existing neural pathways. Multimodal neuroimaging studies have demonstrated distinct topographic patterns of cerebral pathologies in neurodegeneration. For Parkinson’s disease the hypothesis so far rests largely on histopathological evidence of α-synuclein spreading in a characteristic pattern and progressive nigrostriatal dopamine depletion. Functional consequences of nigrostriatal dysfunction on cortical activity remain to be elucidated. Our goal was to investigate multimodal imaging correlates of degenerative processes in Parkinson’s disease by assessing dopamine depletion and its potential effect on striatocortical connectivity networks and cortical metabolism in relation to parkinsonian symptoms. We combined 18F-DOPA-PET, 18F-fluorodeoxyglucose (FDG)-PET and resting state functional MRI to multimodally characterize network alterations in Parkinson’s disease. Forty-two patients with mild-to-moderate stage Parkinson’s disease and 14 age-matched healthy control subjects underwent a multimodal imaging protocol and comprehensive clinical examination. A voxel-wise group comparison of 18F-DOPA uptake identified the exact location and extent of putaminal dopamine depletion in patients. Resulting clusters were defined as seeds for a seed-to-voxel functional connectivity analysis. 18F-FDG metabolism was compared between groups at a whole-brain level and uptake values were extracted from regions with reduced putaminal connectivity. To unravel associations between dopaminergic activity, striatocortical connectivity, glucose metabolism and symptom severity, correlations between normalized uptake values, seed-to-cluster β-values and clinical parameters were tested while controlling for age and dopaminergic medication. Aside from cortical hypometabolism, 18F-FDG-PET data for the first time revealed a hypometabolic midbrain cluster in patients with Parkinson’s disease that comprised caudal parts of the bilateral substantia nigra pars compacta. Putaminal dopamine synthesis capacity was significantly reduced in the bilateral posterior putamen and correlated with ipsilateral nigral 18F-FDG uptake. Resting state functional MRI data indicated significantly reduced functional connectivity between the dopamine depleted putaminal seed and cortical areas primarily belonging to the sensorimotor network in patients with Parkinson’s disease. In the inferior parietal cortex, hypoconnectivity in patients was significantly correlated with lower metabolism (left P = 0.021, right P = 0.018). Of note, unilateral network alterations quantified with different modalities corresponded with contralateral motor impairments. In conclusion, our results support the hypothesis that degeneration of nigrostriatal fibres functionally impairs distinct striatocortical connections, disturbing the efficient interplay between motor processing areas and impairing motor control in patients with Parkinson’s disease. The present study is the first to reveal trimodal evidence for network-dependent degeneration in Parkinson’s disease by outlining the impact of functional nigrostriatal pathway impairment on striatocortical functional connectivity networks and cortical metabolism.
- Subjects :
- Male
0301 basic medicine
Parkinson's disease
physiopathology [Corpus Striatum]
Dopamine
Nigrostriatal pathway
Multimodal Imaging
physiopathology [Cerebral Cortex]
0302 clinical medicine
Neural Pathways
metabolism [Dopamine]
Cerebral Cortex
Putamen
Neurodegeneration
Dopaminergic
Parkinson Disease
Middle Aged
Magnetic Resonance Imaging
Dihydroxyphenylalanine
Substantia Nigra
medicine.anatomical_structure
Female
physiopathology [Parkinson Disease]
metabolism [Parkinson Disease]
Substantia nigra
03 medical and health sciences
Fluorodeoxyglucose F18
metabolism [Fluorodeoxyglucose F18]
metabolism [Substantia Nigra]
medicine
Humans
ddc:610
physiopathology [Substantia Nigra]
Aged
Resting state fMRI
Pars compacta
business.industry
metabolism [Cerebral Cortex]
metabolism [Corpus Striatum]
Functional Neuroimaging
physiopathology [Neural Pathways]
medicine.disease
Corpus Striatum
030104 developmental biology
Case-Control Studies
Positron-Emission Tomography
metabolism [Dihydroxyphenylalanine]
analogs & derivatives [Dihydroxyphenylalanine]
Neurology (clinical)
physiopathology [Putamen]
business
Neuroscience
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 14602156 and 00068950
- Volume :
- 143
- Database :
- OpenAIRE
- Journal :
- Brain
- Accession number :
- edsair.doi.dedup.....dccbcb52ca736332c88200fde51bf533
- Full Text :
- https://doi.org/10.1093/brain/awaa019